FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2566802076> ?p ?o ?g. }

• W2566802076 abstract "Background: Molecularly targeted therapy across tumor types has great potential to benefit cancer patients. In order to validate the assays being used to identify actionable mutations of interest, controls that establish an assay9s limit of detection are needed. 40-60% of melanomas harbor a mutation in proto-oncogene BRAF, resulting in constitutive activation of the RAF/MEK/ERK signaling pathway; driving growth, differentiation and metastasis. Metastatic melanoma patients have a poor prognosis; 5 year survival after diagnosis is only 15%. BRAF mutations are also found in lymphomas, colorectal, thyroid and lung cancers. This study was undertaken to develop reference materials for establishment of the lowest limits of detection for identification of the BRAF V600E mutation with the cobas® 4800 BRAF V600 Mutation test, the THxID TM BRAF kit, the Ion AmpliSeq TM Cancer Hotspot Panel. Reference materials with a limit of detection below 5% are useful for validation and identification of patient tumors with an extremely low percentage of the V600E mutation across multiple types of tumors. Methods: Melanoma cells containing the V600E allele, the V600D allele and the wild type allele were mixed at a range of allelic ratios from 50 to 1% in Histogel and embedded in FFPE. Genomic DNA was extracted from macro-dissected cells in 10μM FFPE sections and analyzed for quality and concentration using the KAPA Biosystems hgDNA Quantification and QC Kit. Quality scores (Q-ratios) generated with the kit may be used to predict the outcome of NGS library construction, with scores close to 1.0 being ideal for sequencing applications. Samples with Q scores close to 1.0, were subsequently tested on an ABI 7500 real time PCR system with the TrimGen BRAF V600 mutation kit. The extracted gDNA and unprocessed FFPE blocks and sections were then sent to diagnostic testing laboratories for analysis on the the cobas® 4800 BRAF V600 Mutation test, the THxID TM BRAF kit, and the Ion AmpliSeq TM Cancer Hotspot Panel. Results: We were able to isolate high quality and quantity (>700ng per 2 10μM curls, Quality scores ∼1.0) gDNA suitable in fragment size and concentration for use in V600 companion diagnostic and NGS analysis from FFPE at a range of allelic ratios. Our 50% and 10% V600E mutant samples were detected by the TrimGen BRAF V600 mutation kit. Testing of mutations below 10% is currently ongoing on companion diagnostic and NGS platforms in clinical diagnostic laboratories. Conclusions: Prototype FFPE and extracted genomic DNA process controls were generated for use in NGS and companion diagnostics for BRAF V600. The advantage of this material is that it contains the mutation of clinical significance at well defined, consistent low levels, at and below the current minimum detectable mutant allele ratio of 10%. These reference controls may allow laboratories to verify assay detection limits, establish run to run reproducibility, and monitor testing quality over time. Citation Format: Cristine L. Chisholm, Russell Garlick, Bharathi Anekella. Controls to detect limit of detection for BRAF V600E as an actionable mutation of interest by NextGen Sequencing and qPCR. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 3394. doi:10.1158/1538-7445.AM2015-3394" @default.
• W2566802076 created "2017-01-06" @default.
• W2566802076 creator A5038797014 @default.
• W2566802076 creator A5039704198 @default.
• W2566802076 creator A5081446707 @default.
• W2566802076 date "2015-08-01" @default.
• W2566802076 modified "2023-09-27" @default.
• W2566802076 title "Abstract 3394: Controls to detect limit of detection for BRAF V600E as an actionable mutation of interest by NextGen Sequencing and qPCR" @default.
• W2566802076 doi "https://doi.org/10.1158/1538-7445.am2015-3394" @default.
• W2566802076 hasPublicationYear "2015" @default.
• W2566802076 type Work @default.
• W2566802076 sameAs 2566802076 @default.
• W2566802076 citedByCount "0" @default.
• W2566802076 crossrefType "proceedings-article" @default.
• W2566802076 hasAuthorship W2566802076A5038797014 @default.
• W2566802076 hasAuthorship W2566802076A5039704198 @default.
• W2566802076 hasAuthorship W2566802076A5081446707 @default.
• W2566802076 hasConcept C104317684 @default.
• W2566802076 hasConcept C121608353 @default.
• W2566802076 hasConcept C126322002 @default.
• W2566802076 hasConcept C135763542 @default.
• W2566802076 hasConcept C180754005 @default.
• W2566802076 hasConcept C184235292 @default.
• W2566802076 hasConcept C2776131300 @default.
• W2566802076 hasConcept C2776470698 @default.
• W2566802076 hasConcept C2777658100 @default.
• W2566802076 hasConcept C2779013556 @default.
• W2566802076 hasConcept C2781249067 @default.
• W2566802076 hasConcept C2994587330 @default.
• W2566802076 hasConcept C501734568 @default.
• W2566802076 hasConcept C502942594 @default.
• W2566802076 hasConcept C526805850 @default.
• W2566802076 hasConcept C54355233 @default.
• W2566802076 hasConcept C57074206 @default.
• W2566802076 hasConcept C71924100 @default.
• W2566802076 hasConcept C86803240 @default.
• W2566802076 hasConceptScore W2566802076C104317684 @default.
• W2566802076 hasConceptScore W2566802076C121608353 @default.
• W2566802076 hasConceptScore W2566802076C126322002 @default.
• W2566802076 hasConceptScore W2566802076C135763542 @default.
• W2566802076 hasConceptScore W2566802076C180754005 @default.
• W2566802076 hasConceptScore W2566802076C184235292 @default.
• W2566802076 hasConceptScore W2566802076C2776131300 @default.
• W2566802076 hasConceptScore W2566802076C2776470698 @default.
• W2566802076 hasConceptScore W2566802076C2777658100 @default.
• W2566802076 hasConceptScore W2566802076C2779013556 @default.
• W2566802076 hasConceptScore W2566802076C2781249067 @default.
• W2566802076 hasConceptScore W2566802076C2994587330 @default.
• W2566802076 hasConceptScore W2566802076C501734568 @default.
• W2566802076 hasConceptScore W2566802076C502942594 @default.
• W2566802076 hasConceptScore W2566802076C526805850 @default.
• W2566802076 hasConceptScore W2566802076C54355233 @default.
• W2566802076 hasConceptScore W2566802076C57074206 @default.
• W2566802076 hasConceptScore W2566802076C71924100 @default.
• W2566802076 hasConceptScore W2566802076C86803240 @default.
• W2566802076 hasLocation W25668020761 @default.
• W2566802076 hasOpenAccess W2566802076 @default.
• W2566802076 hasPrimaryLocation W25668020761 @default.
• W2566802076 hasRelatedWork W1270134304 @default.
• W2566802076 hasRelatedWork W130293398 @default.
• W2566802076 hasRelatedWork W1480629901 @default.
• W2566802076 hasRelatedWork W1876354503 @default.
• W2566802076 hasRelatedWork W1969034070 @default.
• W2566802076 hasRelatedWork W1995439820 @default.
• W2566802076 hasRelatedWork W2043145553 @default.
• W2566802076 hasRelatedWork W2056902101 @default.
• W2566802076 hasRelatedWork W2070479805 @default.
• W2566802076 hasRelatedWork W2113716683 @default.
• W2566802076 hasRelatedWork W2315632947 @default.
• W2566802076 hasRelatedWork W2332743996 @default.
• W2566802076 hasRelatedWork W2343736608 @default.
• W2566802076 hasRelatedWork W2409409600 @default.
• W2566802076 hasRelatedWork W2574446840 @default.
• W2566802076 hasRelatedWork W2581476011 @default.
• W2566802076 hasRelatedWork W2966933527 @default.
• W2566802076 hasRelatedWork W3159216397 @default.
• W2566802076 hasRelatedWork W3205855541 @default.
• W2566802076 hasRelatedWork W832584340 @default.
• W2566802076 isParatext "false" @default.
• W2566802076 isRetracted "false" @default.
• W2566802076 magId "2566802076" @default.
• W2566802076 workType "article" @default.